2022 R&D Spend: For the year ended March 31, 2023, Daiichi Sankyo spent 341.57 billion JPY ($2.60 billion USD) on R&D, a 31.21 percent increase from the 260.33 billion JPY ($2.37 billion USD) the company spent on R&D for the year ended March 31, 2022
Wintzell, E
She regularly ferries them to and from wrestling and cheerleading practices, and they have sleepovers at her apartment on Friday nights
More than 10 million claims for Ozempic were submitted in 2024, up from 524,000 in 2019 (an 82% average annual growth rate) and another 5.1 million for Mounjaro, up from 122,000 in 2022 (average annual growth of 549%)
a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)
GLP-1 medications may indirectly improve ED by tackling obesity and its related health problems